These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15988069)

  • 61. Detergents stabilize the conformation of phosphodiesterase 6.
    Baker BY; Palczewski K
    Biochemistry; 2011 Nov; 50(44):9520-31. PubMed ID: 21978030
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Non-arteritic anterior ischemic optic neuropathy, PDE-5 inhibitors, and amiodarone: may there be a sex hormone effect for the eye?
    Verit A
    Med Hypotheses; 2007; 69(2):470-1. PubMed ID: 17280789
    [No Abstract]   [Full Text] [Related]  

  • 63. PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries.
    Santos-Silva AJ; Cairrão E; Morgado M; Alvarez E; Verde I
    Eur J Pharmacol; 2008 Mar; 582(1-3):102-9. PubMed ID: 18234184
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease.
    Cheng J; Grande JP
    Exp Biol Med (Maywood); 2007 Jan; 232(1):38-51. PubMed ID: 17202584
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Tadalafil, a long-acting type 5 phosphodiesterase isoenzyme inhibitor, improves neurological functional recovery in a rat model of embolic stroke.
    Zhang L; Zhang Z; Zhang RL; Cui Y; LaPointe MC; Silver B; Chopp M
    Brain Res; 2006 Nov; 1118(1):192-8. PubMed ID: 16959227
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A FYVE-containing unusual cyclic nucleotide phosphodiesterase from Trypanosoma cruzi.
    Kunz S; Oberholzer M; Seebeck T
    FEBS J; 2005 Dec; 272(24):6412-22. PubMed ID: 16336277
    [TBL] [Abstract][Full Text] [Related]  

  • 67. PDE5 inhibition and fibrosis.
    Corbin J
    Int J Impot Res; 2005; 17(6):546. PubMed ID: 16258527
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Novel pyrazolopyrimidopyridazinones with potent and selective phosphodiesterase 5 (PDE5) inhibitory activity as potential agents for treatment of erectile dysfunction.
    Giovannoni MP; Vergelli C; Biancalani C; Cesari N; Graziano A; Biagini P; Gracia J; Gavaldà A; Dal Piaz V
    J Med Chem; 2006 Aug; 49(17):5363-71. PubMed ID: 16913726
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Structural elements of molecules of GTP-binding proteins and effectors mediating coupling between them].
    Shpakov AO
    Ukr Biokhim Zh (1978); 1997; 69(1):3-20. PubMed ID: 9454374
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Acute phosphodiesterase 5 inhibition mimics hemodynamic effects of B-type natriuretic peptide and potentiates B-type natriuretic peptide effects in failing but not normal canine heart.
    Forfia PR; Lee M; Tunin RS; Mahmud M; Champion HC; Kass DA
    J Am Coll Cardiol; 2007 Mar; 49(10):1079-88. PubMed ID: 17349888
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Quinazolines as potent and highly selective PDE5 inhibitors as potential therapeutics for male erectile dysfunction.
    Kim YH; Choi H; Lee J; Hwang IC; Moon SK; Kim SJ; Lee HW; Im DS; Lee SS; Ahn SK; Kim SW; Han CK; Yoon JH; Lee KJ; Choi NS
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6279-82. PubMed ID: 18976905
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cryo-EM structure of phosphodiesterase 6 reveals insights into the allosteric regulation of type I phosphodiesterases.
    Gulati S; Palczewski K; Engel A; Stahlberg H; Kovacik L
    Sci Adv; 2019 Feb; 5(2):eaav4322. PubMed ID: 30820458
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Methyl-β-cyclodextrin is a useful compound for extraction and purification of prenylated enzymes from the retinal disc membrane.
    Saito N; Ishida Y; Seno K; Hayashi F
    Protein Expr Purif; 2012 Mar; 82(1):168-73. PubMed ID: 22226869
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The Molecular Organization of Human cGMP Specific Phosphodiesterase 6 (PDE6): Structural Implications of Somatic Mutations in Cancer and Retinitis Pigmentosa.
    Maryam A; Vedithi SC; Khalid RR; Alsulami AF; Torres PHM; Siddiqi AR; Blundell TL
    Comput Struct Biotechnol J; 2019; 17():378-389. PubMed ID: 30962868
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Reverse fingerprinting, similarity searching by group fusion and fingerprint bit importance.
    Williams C
    Mol Divers; 2006 Aug; 10(3):311-32. PubMed ID: 17031535
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Catalytic effectiveness of subunits of a dimeric molecule of aminotransferase in solution and in crystalline form].
    Kochkina VM
    Mol Biol (Mosk); 2000; 34(5):901-6. PubMed ID: 11033820
    [No Abstract]   [Full Text] [Related]  

  • 77. Domain organization and conformational plasticity of the G protein effector, PDE6.
    Zhang Z; He F; Constantine R; Baker ML; Baehr W; Schmid MF; Wensel TG; Agosto MA
    J Biol Chem; 2015 Jul; 290(28):17131-2. PubMed ID: 26163476
    [No Abstract]   [Full Text] [Related]  

  • 78. Catalytic, Asymmetric Dimerization of Methylketene.
    Calter MA
    J Org Chem; 1996 Nov; 61(23):8006-8007. PubMed ID: 11667781
    [No Abstract]   [Full Text] [Related]  

  • 79. Analysis of dimerization determinants of PDE6 catalytic subunits.
    Muradov KG; Boyd KK; Artemyev NO
    Methods Mol Biol; 2005; 307():263-75. PubMed ID: 15988069
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Interactions between catalytic and inhibitory subunits of PDE6.
    Artemyev NO
    Methods Mol Biol; 2005; 307():277-88. PubMed ID: 15988070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.